Table 2 Preoperative lab test between patients in non-LNM and LNM groups
From: Risk factors for lymph node metastasis in gastric neuroendocrine tumor: a retrospective study
Non-LNM (n = 37) | LNM (n = 82) | P-value | |
|---|---|---|---|
WBC (× 109/L) | 5.64 ± 1.55 | 6.35 ± 2.38 | 0.097 |
Neutrophils (× 109/L) | 3.53 ± 1.24 | 3.92 ± 2.13 | 0.307 |
Lymphocytes (× 109/L) | 1.56 ± 0.50 | 1.52 ± 0.61 | 0.749 |
Monocytes (× 109/L) | 0.69 ± 1.39 | 0.52 ± 0.75 | 0.412 |
Hb (g/L) | 121.43 ± 26.31 | 114.01 ± 25.61 | 0.150 |
PLT (× 109/L) | 236.84 ± 85.12 | 228.91 ± 87.55 | 0.646 |
ALB (g/L) | 39.93 ± 4.71 | 36.63 ± 5.69 | 0.003* |
CRP (mg/L) | 8.18 ± 14.88 | 16.70 ± 32.75 | 0.134 |
NLR | 2.41 ± 0.88 | 3.00 ± 2.81 | 0.226 |
PLR | 159.63 ± 58.80 | 165.78 ± 101.28 | 0.739 |
OPNI | 46.03 ± 9.78 | 43.54 ± 8.54 | 0.166 |
Fecal occult blood test (n, %) | 0.428 | ||
Negative | 28 (75.7%) | 56 (68.3%) | – |
Positive | 4 (10.8%) | 13 (15.9%) | – |
Unknown | 5 (13.5%) | 13 (15.9%) | – |
AFP (ng/ml) | 9.90 ± 27.94 | 5.30 ± 18.41 | 0.320 |
CEA (ng/ml) | 2.41 ± 3.29 | 12.25 ± 23.78 | 0.020* |
CA125 (U/ml) | 23.84 ± 68.17 | 13.05 ± 15.03 | 0.203 |
CA199 (U/ml) | 9.29 ± 7.14 | 27.82 ± 96.43 | 0.274 |
CA242 (U/ml) | 4.05 ± 3.16 | 6.60 ± 9.92 | 0.213 |
CA724 (U/ml) | 2.18 ± 3.56 | 6.88 ± 23.36 | 0.312 |
INR | 1.01 ± 0.77 | 1.04 ± 0.78 | 0.034* |
APPT (s) | 26.41 ± 5.10 | 28.25 ± 5.30 | 0.081 |
PT (s) | 17.66 ± 3.31 | 18.32 ± 1.85 | 0.171 |
TT (s) | 11.53 ± 0.87 | 11.96 ± 0.94 | 0.018* |